1. 1) Wang, J. C., DNA topoisomerases. Annu. Rev. Biochem. 54, 665-697 (1985).
2. 2) D'Arpa, P., and Liu, L. F., Topoisomerase-targeting antitumor drugs. Biochim. Biophys. Acta, 989, 163-177 (1989).
3. 3) Tewey, K. M., Rowe, T. C., Yang, L., Halligan, B. D., and Liu, L. F., Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II. Science, 226, 466-468 (1984).
4. 4) Nelson, E. M., Tewey, K. M., and Liu, L. F., Mechanism of antitumor drug action: poisoning of mammalian DNA topoisomerase II on DNA by 4′-(9-acridinylamino)-methanesulfon-m-anisidide. Proc. Natl. Acad. Sci. U.S.A. 81, 1361-1365 (1984).
5. 5) Tewey, K. M., Chen, G. L., Nelson, E. M., and Liu, L. F., Intercalative antitumor drugs interfere with the breakage-reunion reaction of mammalian DNA topoisomerase II. J. Biol. Chem. 259, 9182-9187 (1984).